News

UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.

CVS is benefiting from pharmacy growth, AI investments and a discounted valuation, but reimbursement pressure and regulatory scrutiny remain key risks.

The S&P 500 Index ($SPX ) (SPY ) is down -0.54% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.96%. E-mini S&P futures (ESU26 ) are down -0.50%, and September E-mini Nasdaq futures (NQU26...

CVS Health (NYSE:CVS) executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds. Speaking at an investor conference, Chief Financial Of

UnitedHealth Group (NYSE:UNH) executives said the company’s turnaround remained on track, citing continued strength in Medicare Advantage, Medicaid performance that is tracking toward the favorable end of expectations, and operational improvements at Optum Health. Speaking at an investor conference

UnitedHealth Group Incorporated’s (NYSE:UNH) insurance unit is removing prior-authorization requirements from a broad range of healthcare services beginning October 1. The changes form part of UnitedHealthcare’s plan to eliminate such requirements for 30% of healthcare services by the end of 2026. The initiative could reduce administrative work for patients, providers, and the insurer itself while […]

The latest trading day saw UnitedHealth Group (UNH) settling at $393.06, representing a -1.94% change from its previous close.

Healthcare stocks were lower late Wednesday afternoon with the NYSE Healthcare Index and the State S

UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.

On September 3, a caller asked if UnitedHealth Group Incorporated (NYSE:UNH) has enough profitable growth that they should consider adding it to their portfolio. Mad Money host Jim Cramer replied: Yes, the answer: it does, it does. You know, I’ve got to tell you, I thought that last quarter was very, very good. The stock […]

CVS Health noted a continuation of "high-trend" medical cost growth at a Wells Fargo investor conference on Wednesday, helping to put a spring in the step of hospital stocks including HCA Healthcare, while souring the mood of managed care investors. Shares of CVS stock came away relatively unscathed, while UnitedHealth slipped and Oscar Health stumbled. CVS management's comments about medical cost trends were brief and vague, while Wells Fargo conference presentations by HCA and Universal Health Services didn't appear to provide updates to Q3 trends since Q2 earnings calls.

Healthcare stocks were lower Wednesday afternoon, with the NYSE Healthcare Index down 0.3% and the S

UnitedHealth's Optum Health Faces Major Shift as TPG Enters the Picture

All three major US stock indexes were down in late-morning trading Wednesday, as oil prices climbed,

UNH is investing nearly $1.5B in AI to expand Optum Insight's software offerings, boost efficiency and unlock new growth opportunities.

TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.

UnitedHealth Group Inc. has sold an interest in some of its Optum Health operations in Florida to private equity company TPG Inc. as the health conglomerate is working to recover from a collapse in profits last year.

Michael Burry, the Scion Asset Management founder made famous by The Big Short, has rotated hard into three names Wall Street left for dead. According to a portfolio breakdown circulating this week, his largest position is UNH calls at 18.88%, followed by REGN calls at 18.16% and LULU calls at 16.43%. Nine of ten disclosed […]

While short-term volatility may persist, many signs suggest UnitedHealth Group's turnaround remains in motion.

Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.

UnitedHealth’s 37.1% return over the past six months has outpaced the S&P 500 by 25.4%, and its stock price has climbed to $400.22 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Less paperwork may improve access, but investors must watch whether faster approvals weaken medical-cost discipline.

UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.

In recent months, UnitedHealth Group has reported better-than-expected earnings, raised its full-year adjusted EPS outlook, tightened medical cost trends, and moved to remove prior authorization requirements for a wide range of services while accelerating payments to rural hospitals. These steps suggest UnitedHealth Group is reshaping how it manages care delivery and insurer‑provider relationships, potentially reducing bureaucracy and improving member and clinician experience across its vast...

CVS Health has outperformed the broader market over the past year, while analysts remain highly bullish on its future prospects.

This recovery story is turning into a success story.

September's rate and oil pressures could drive sector rotation, favoring energy, financials and defensive healthcare over growth stocks.

UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.

UNH is showing signs of recovery as medical costs improve, Optum gains momentum and 2026 earnings guidance rises.

Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]